Zacary Germon

University of Newcastle Australia

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (11)

Patrick Connerty

Associate Lecturer

University of New South Wales - Randwick Campus

AUSTRALIA

View details

Muhammad Fairuz Jamaluddin

Lecturer

Newcastle University

AUSTRALIA

View details

Mika L. Persson

Newcastle University

AUSTRALIA

View details

Brett Nixon

Professor

Newcastle University

AUSTRALIA

View details

Heather Lee

University of Newcastle Australia

AUSTRALIA

View details

Matthew Dun

Hunter Medical Research Institute

AUSTRALIA

View details

Santosh Valvi

University of Western Australia

AUSTRALIA

View details

Raelene Endersby

University of Western Australia

AUSTRALIA

View details

David A. Skerrett‐Byrne

College of Engineering

AUSTRALIA

View details

Jonathan Morris

University of New South Wales

AUSTRALIA

View details

Adjanie Patabendige

Associate Professor of Biomedical Science

University of Derby

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zacary Germon

Research Interests

Explore related searches

Contact this professor

Articles (10)

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to recision therapies

Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection

Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine Responses

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma

Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia.

Collaborators (11)

Patrick Connerty

Muhammad Fairuz Jamaluddin

Mika L. Persson

Brett Nixon

Heather Lee

Matthew Dun

Santosh Valvi

Raelene Endersby

David A. Skerrett‐Byrne

Jonathan Morris

Adjanie Patabendige

Make your next move.